Equities

Aton SA

Aton SA

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)0.012
  • Today's Change0.000 / -1.64%
  • Shares traded453.14k
  • 1 Year change-55.88%
  • Beta1.0430
Data delayed at least 15 minutes, as of Nov 14 2024 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Aton SA, formerly known as Hybrigenics SA is France-based Company engaged in the biotechnological sector. It specializes in the research and development of drugs intended for cancer treatment and supplies scientific services in the protein interaction field. The Company is specialized in the research and development (R&D) of drugs to fight cancer. It is organized in two units: Hybrigenics Pharma for internal R&D, which develops a research program aimed at such diseases as melanoma and prostate cancer; and Hybrigenics Services for commercial business, mainly engaged in protein interaction information and solutions. Hybrigenics SA’s main development program is based on inecalcitol, a vitamin D analogue, for prostate cancer treatment. It operates through Hybrigenics Corporation and Imaxio.

  • Revenue in EUR (TTM)1.56k
  • Net income in EUR-563.57k
  • Incorporated1998
  • Employees17.00
  • Location
    Aton SA850 Boulevard Sebastien BrantILLKIRCH-GRAFFENSTADEN 67400FranceFRA
  • Phone+33 158103800
  • Fax+33 158103849
  • Websitehttps://www.aton-group.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Aton SA1.56k-563.57k9.58m17.00------6,141.37-0.0021-0.00210.00001-------------47.55---60.70-23,780.77---36,126.28-3,320.95--------24,396.7937.77-3,244.13------
Bluelinea SA9.51m-1.68m11.42m84.00--7.8263.131.20-0.1372-0.13720.77410.11890.8625-0.93738.45110,538.80-15.28-26.29-37.21-58.29103.2292.43-17.72-29.240.4416-22.160.7559---5.599.78-4.91--20.53--
Mauna Kea Technologies SA7.54m-11.21m11.64m65.00------1.55-0.2155-0.21550.1456-0.31480.35561.994.10110,823.50-56.61-51.23-142.92-93.3011.4811.15-159.20-142.410.6603-12.873.50--40.139.1666.66---21.16--
Spineguard SA4.31m-4.18m12.06m24.00--1.80--2.80-0.107-0.1070.11040.12560.38271.284.68179,700.00-37.12-23.69-52.43-42.7372.8975.60-97.00-45.021.73-13.510.3384---22.98-10.65-74.81--89.42--
Alpha Mos SA4.51m-4.74m12.83m53.00------2.85-0.4345-0.43450.4127-0.74280.5992.937.3685,000.00-63.06-47.80-521.78-139.0945.5568.00-105.28-68.640.2498-7.77-----22.464.97-76.91---18.75--
Laboratoires Euromedis SA27.62m18.14m13.71m54.000.760.61610.77070.49666.286.289.697.740.55151.802.92511,421.7036.248.7646.0112.4534.1615.5765.706.102.57-21.220.2906---37.18--320.97------
Intrasense SA2.33m-3.89m14.52m74.00--2.73--6.23-0.0751-0.07510.0450.1010.2136--2.4731,486.49-35.65-29.51-45.95-43.1291.0787.59-166.91-54.42---36.920.2074---12.801.53-4.65------
Diagnostic Medical Systems SA44.21m-14.97m15.20m143.00--1.22--0.3439-0.7915-0.54152.500.68620.88331.904.93300,761.90-30.18-12.33-57.32-22.1438.0037.72-34.17-16.450.6439-6.430.5991--19.5111.62-106.30------
Theraclion SA1.28m-3.56m16.18m28.00--4.88--12.61-0.0769-0.07690.02750.07190.0718-0.01031.0344,235.86-19.94-32.98-26.41-48.01102.4860.85-277.68-249.162.69--0.3303--47.49-1.1325.97---7.23--
Implanet SA7.30m-6.91m16.25m41.00--4.64--2.23-0.1305-0.12260.09790.0280.52270.79273.83179,262.90-49.48-37.44-111.96-86.7455.2259.59-94.67-67.430.5906-14.510.5671---7.242.08-88.59---2.20--
Global Bioenergies SA486.06k-7.36m16.33m45.00--3.53--33.59-0.4036-0.40360.02670.2550.02765.060.459910,566.52-41.78-43.66-60.78-82.47-1,192.39-948.35-1,514.49-1,331.362.79--0.5044--365.8336.2527.78---19.49--
Ikonisys SA617.19k-2.70m16.36m10.00--0.9752--26.51-0.2672-0.26720.06111.510.02520.81033.4061,719.00-11.01---14.76--0.943---437.39--0.0691-30.680.1686---27.28--7.38------
Biosynex SA104.03m-38.63m30.35m521.00--0.2853--0.2917-3.70-3.709.969.890.43260.59787.67180,913.00-16.0814.90-27.5719.4124.6751.92-37.1814.610.4005-12.580.3783---52.7024.40-337.76------
Data as of Nov 14 2024. Currency figures normalised to Aton SA's reporting currency: Euro EUR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.